AAMU
BMRN icon

APG Asset Management US’s BioMarin Pharmaceuticals BMRN Stock Holding History

APG Asset Management US’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,934
Closed -$216K – 73
2025
Q3 		$216K Hold
3,934
– – ﹤0.01% 184
2025
Q2 		$221K Hold
3,934
– – ﹤0.01% 188
2025
Q1 		$267K Hold
3,934
– – ﹤0.01% 191
2024
Q4 		$259K Sell
3,934
-474
-11% -$31.7K ﹤0.01% 198
2024
Q3 		$309K Sell
4,408
-49,400
-92% -$4.13M ﹤0.01% 151
2024
Q2 		$4.42M Buy
53,808
+1,328
+3% +$111K 0.03% 148
2024
Q1 		$4.57M Buy
52,480
+16,579
+46% +$1.48M 0.03% 154
2023
Q4 		$3.46M Buy
+35,901
New +$3.18M 0.02% 153

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return